Strategies for liver support: From stem cells to xenotransplantation

Journal of Hepatology

Volumn 41, Issue 6, 2004, Pages 1050-1059

  Burra, Patrizia ^a   Samuel, Didier ^b   Wendon, Julia ^c   Pietrangelo, Antonello ^d   Gupta, Sanjeev ^e  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b HÔPITAL PAUL BROUSSE   (France)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSPLANTATION; CONFERENCE PAPER; DENDRITIC CELL; ENDOTHELIUM CELL; GENETIC MANIPULATION; HUMAN; LIVER CELL; LIVER PARENCHYMA; LIVER REGENERATION; LIVER TRANSPLANTATION; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; STEM CELL; XENOTRANSPLANTATION;

ANIMALS; HEPATOCYTES; HUMANS; LIVER; LIVER DISEASES; LIVER REGENERATION; LIVER, ARTIFICIAL; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 9644287903     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.10.003     Document Type: Conference Paper

References (103)

1. J.A. Rhim, E.P. Sandgren, J.L. Degen, R.D. Palmiter, and R.L. Brinster Replacement of diseased mouse liver by hepatic cell transplantation Science 263 1994 1149 1152
2. K. Overturf, M. Al-Dhalimy, R. Tanguay, M. Brantly, C.N. Ou, and M. Finegold Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I Nat Genet 12 1996 266 273
3. A. Mignon, J.E. Guidotti, C. Mitchell, M. Fabre, A. Wernet, and A. De La Coste Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes Nat Genet 4 1998 118 1188
4. E. Laconi, R. Oren, D.H. Mukhopadhyay, E. Hurstin, S. Laconi, and P. Pani Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine Am J Pathol 153 1998 319 329
5. C. Guha, A. Sharma, S. Gupta, A. Alfieri, G.R. Gorla, and S. Gagandeep Amelioration of radiation induced liver damage in partially hepatectomized rats by hepatocyte transplantation Cancer Res 59 1999 5871 5874
6. H. Malhi, G.R. Gorla, A.N. Irani, P. Annamaneni, and S. Gupta Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation Proc Natl Acad Sci USA 99 2002 13114 13119
7. M. Grossman, S.E. Raper, K. Kozarsky, E.A. Stein, J.F. Engelhardt, and D. Muller Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia Nature Genet 6 1994 335 341
8. M. Grossman, D.J. Rader, D.W. Muller, D.M. Kolanky, K. Kozarsky, and B.J. Clark III A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia Nat Med 1 1995 1148 1154
9. C. Giannini, S. Morosan, J.G. Tralhao, J.E. Guidotti, S. Battaglia, and K. Mollier A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector Hepatology 38 2003 114 122
10. T.H. Nguyen, J. Oberholzer, J. Birraux, P. Majno, P. Morel, and D. Trono Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes Mol Ther 6 2002 199 209
11. J. Cai, M. Ito, K.A. Westerman, N. Kobayashi, P. Leboulch, and I.J. Fox Construction of a nontumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen J Hepatol 33 2000 701 708
12. H. Wege, M.S. Chui, H.T. Le, S.C. Strom, and M.A. Zern In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging Cell Transplant 12 2003 897 906
13. M. Zalzman, S. Gupta, R.K. Giri, I. Berkovic, B.S. Sappal, and O. Karnieli Reversal of hyperglycemia in mice by using human expandable insulin-producing cells diffentiated from fetal liver progenitor cells PNAS 100 2003 7253 7258
14. B.E. Petersen, W.C. Bowen, K.D. Patrene, W.M. Mars, A.K. Sullivan, and N. Murase Bone marrow as a potential source of hepatic oval cells Science 284 1999 1168 1170
15. N.D. Theise, S. Badve, R. Saxena, O. Henegariu, S. Sell, and J.M. Crawford Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation Hepatology 31 2000 235 240
16. E. Lagasse, H. Connors, M. Al-Dhalimy, M. Reitsma, M. Dohse, and L. Osborne Purified hematopoietic stem cells can differentiate into hepatocytes in vivo Nat Med 6 2000 1212 1213
17. N.D. Theise, M. Nimmakayalu, R. Gardner, P.B. Illei, G. Morgan, and L. Teperman Liver from bone marrow in humans Hepatology 32 2000 11 16
18. M.R. Alison, R. Poulsom, R. Jeffery, A.P. Dhillon, A. Quaglia, and J. Jacob Hepatocytes from nonhuman adult stem cells Nature 406 2000 257 258
19. A.J. Wagers, R.I. Sherwood, J.L. Christensen, and I.L. Weissman Little evidence for developmental plasticity of adult hematopoietic stem cell Science 297 2002 2256 2259
20. V.O. Mallet, C. Mitchell, E. Mezey, M. Fabre, J.E. Guidotti, and L. Renia Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo Hepatology 35 2002 799 804
21. X. Wang, E. Montini, M. Al-Dhalimy, E. Lagasse, M. Fineglod, and M. Grompe Kinetics of liver repopulation after bone marrow transplantation Am J Pathol 161 2002 349 350
22. X. Wang, H. Willenbring, Y. Akkari, Y. Torimaru, M. Foster, and M. Al-Dhalimy Cell fusion is the principal source of bone-marrow-derived hepatocytes Nature 422 2003 897 901
23. G. Vassilopoulos, P.R. Wang, and D.W. Russell Transplanted bone marrow regenerates liver by cell fusion Nature 422 2003 901 904
24. F.V. Chisari, and C. Ferrari Hepatitis B virus immunopathogenesis Ann Rev Immunol 13 1995 29 60
25. F.D. Camargo, M. Finegold, and M.A. Goodell Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners J Clin Invest 113 2004 1266 1270
26. H. Willenbring, A.S. Bailey, M. Foster, Y. Akkari, C. Dorrell, and S. Olson Myelomonocytic cells are sufficient for therapeutic cell fusion in liver Nat Med 10 2004 744 748
27. C. Holden Stem cell research. Advocates keep pot boiling as Bush plans new centers Science 305 2004 461
28. Y.Y. Jang, M.I. Collector, S.B. Baylin, A.M. Diehl, and S.J. Sharkis Hematopoietic stem cells convert into liver cells within days without fusion Nat Cell Biol 6 2004 532 539
29. P.N. Newsome, I. Johannessen, S. Boyle, E. Dalakas, K.A. McAulay, and K. Samuel Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion Gastroenterology 124 2003 1891 1900
30. S.J. Forbes, F.P. Russo, V. Rey, P. Burra, M. Rugge, and N.A. Wright A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis Gastroenterology 126 2004 955 963
31. A.S. Bailey, S. Jiang, M. Afentoulis, C.I. Baumann, D.A. Schroeder, and S.B. Olson Transplanted adult hematopoietic stem cells differentiate into functional endothelial cells Blood 3 2004 13 19
32. N. Fausto Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells Hepatology 39 2004 1477 1487
33. J.E. Ros, L. Libbrecht, M. Geuken, P.L. Jansen, and T.A. Roskams High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease J Pathol 200 2003 547 550
34. K. Shimano, M. Satake, A. Okaya, J. Kitanaka, N. Kitanaka, and M. Takemura Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1 Am J Pathol 163 2003 3 9
35. N.D. Theise, and D.S. Krause Bone marrow to liver: the blood of Prometheus Semin Cell Dev Biol 13 2002 411 417
36. X. Wang, M. Foster, M. Al-Dhalimy, E. Lagasse, M. Finegold, and M. Grompe The origin and liver repopulating capacity of murine oval cells PNAS 100 2003 11881 11888
37. O. Yasui, N. Miura, K. Terada, Y. Kawarada, K. Koyama, and T. Sugiyama Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver Hepatology 25 1997 329 334
38. R. Troisi, O. Cuomo, and B. De Hemptinne Adult-to-adult living-related liver transplantation using the right hepatic lobe Dig Liver Dis 32 2000 243 244
39. I.R. Kamel, N. Erbay, G. Warmbrand, J.B. Kruskal, E.A. Pomfret, and V. Raptopoulos Liver regeneration after living adult right lobe transplantation Abdom Imaging 28 2003 53 57
40. T. Fujikawa, T. Hirose, H. Fujii, S. Oe, K. Yasuchika, and H. Azuma Purification of adult hepatic progenitor cells using green fluorescent protein (GFP)-transgenic mice and fluorescence-activated cell sorting J Hepatol 39 2003 162 170
41. G. Vassilopoulos, P.R. Wang, and D.W. Russell Transplanted bone marrow regenerates liver by cell fusion Nature 422 2003 901 904
42. K. Overturf, M. Al-Dhalimy, R. Tanguay, M. Brantly, C.N. Ou, and M. Finegold Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I Nat Genet 12 1996 266 273
43. R.L. Reinhardt, A. Khoruts, R. Merica, T. Zell, and M.K. Jenkins Visualizing the generation of memory CD4 T cells in the whole body Nature 410 2001 101 105
44. D. Masopust, V. Vezys, A.L. Marzo, and L. Lefrancois Preferential localization of effector memory cells in nonlymphoid tissue Science 291 2001 2413 2417
45. K. Matsuno, T. Ezaki, S. Kudo, and Y. Uehara A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph J Exp Med 183 1996 1287 1292
46. A.J. Grant, S. Goddard, J. Ahmed-Choudhury, G. Reynolds, D.G. Jackson, and M. Briskin Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal associated lymphoid tissue in chronic inflammatory liver disease Am J Pathol 160 2002 1445 1455
47. A. Bonacchi, I. Petrai, R.M. Defranco, E. Lazzeri, F. Annunziato, and I. Efsen The chemokine CCL 21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 125 2003 1060 1076
48. T. Saiki, T. Ezaki, M. Ogawa, and K. Matsuno Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes Transplantation 71 2001 1806 1815
49. Z.X. Lian, T. Okada, X.S. He, Y.J. Liu, A.A. Ansari, and K. Kikuchi Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations J Immunol 170 2003 2323 2330
50. P.J. O'Connell, W. Li, Z. Wang, S.M. Specht, A.J. Logar, and A.W. Thomson Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts J Immunol 168 2002 143 154
51. P.J. O'Connell, W. Li, T. Takayama, A.J. Logar, S. Qian, and A.W. Thomson CD8alpha+(lymphoid related) and CD8alpha- (myeloid) dendritic cells differentially regulate vascularized organ allograft survival Transplant Proc 33 2001 94
52. P.A. Knolle, A. Uhrig, S. Hegenbarth, E. Loser, E. Schmitt, and G. Gerken IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules Clin Exp Immunol 114 1998 427 433
53. A. Limmer, and P.A. Knolle Liver sinusoidal endothelial cells: a new type of organ-resident antigen presenting cell Arch Immunol Ther Exp 49 2001 S7 S11
54. P.A. Knolle, and G. Gerken Local control of the immune response in the liver Immunol Rev 174 2000 21 34
55. P. Bertolino, D.G. Bowen, G.W. McCaughan, and B. Fazekas de St Groth Antigen-specific primary activation of CD8+ T cells within the liver Immunology 166 2001 5430 5438
56. I.N. Crispe Hepatic T cells and liver tolerance Nat Rev Immunol 3 2003 51 62
57. A. Limmer, T. Sacher, J. Alferink, M. Kretschmar, G. Schonrich, and T. Nichterlein Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment Eur J Immunol 28 1998 2395 2406
58. Z.X. Liu, S. Govindarajan, S. Okamoto, and G. Dennert Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver J Immunol 166 2001 3035 3041
59. S.C. Afford, S. Randhawa, A.G. Eliopoulos, S.G. Hubscher, L.S. Young, and D.H. Adams CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection J Exp Med 189 1999 441 446
60. J. Ahmed-Choudhury, C.L. Russell, S. Randhawa, L.S. Young, D.H. Adams, and S.C. Afford Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation Mol Biol Cell 14 2003 1334 1345
61. T.A. Roskams, L. Libbrecht, and V.J. Desmet Progenitor cells in diseased human liver Semin Liver Dis 23 2003 385 396
62. R.N. Bhandari, L.A. Riccalton, A.L. Lewis, J.R. Fry, A.H. Hammond, and S.J. Tendler Liver tissue engineering: a role for co-culture systems in modifying hepatocyte function and viability Tissue Eng 7 2001 345 357
63. J.J. Cho, B. Joseph, B.S. Sappal, R.K. Giri, R. Wang, and J.W. Ludlow Analysis of the functional integrity of cryopreserved human liver cells including xenografting in immunodeficient mice to address suitability for clinical applications Liver Int 4 2004 361 370
64. B. Reddy, S. Gupta, Y. Chuzhin, A. Kalergis, L. Budhai, and M. Zhang The effect of CD28/B7 blockade on alloreactive T and B cells after liver cells transplantation Transplantation 71 2001 801 811
65. I.J. Fox, and R. Chowdhury Hepatocyte transplantation Am J Transpl 4 2004 7 13
66. M. Muraca, G. Gerunda, D. Neri, M.T. Vilei, A. Granato, and P. Feltracco Hepatocyte transplantation as a treatment for glycogen storage disease type 1a Lancet 26 2003 317 318
67. I.J. Fox, and R. Chowdhury Hepatocyte transplantation J Hepatol 40 2004 878 886
68. L. De Bartolo, G. Jarosch-Von Schweder, A. Haverich, and A. Bader A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions Biotechnol Prog 16 2000 102 108
69. A. Strain, and J.M. Neuberger A bioartificial liver - state of the art Science 295 2002 1005 1009
70. J.C. Gerlach, K. Mutig, I.M. Sauer, P. Scharade, E. Efimova, and T. Mieder Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study Transplantation 76 2003 781 786
71. R.A. Chamuleau Artificial liver support in the third millennium Artif Cells Blood Substit Immobil Biotechnol 31 2003 117 126
72. N.L. Sussman, and J.H. Kelly Extracorporeal liver support: cell-based therapy for the failing liver Am J Kidney Dis 30 1997 S66 S71
73. A.A. Demetriou, R.S. Brown Jr, R.W. Busuttil, J. Fair, B.M. McGuire, and P. Rosenthal Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure Ann Surg 239 2004 660 667
74. M. Irgang, I.M. Sauer, A. Karkas, K. Zeilinger, J.C. Gerlach, and R. Kurth Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells J Clin Virol 28 2003 141 154
75. I.M. Sauer, D. Kardassis, K. Zeillinger, A. Pascher, A. Gruenwald, and G. Pless Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells Xenotransplantation 10 2003 460 469
76. B. Busse, and J.C. Gerlach Bioreactors for hybrid liver support: historical aspects and novel designs Ann NY Acad Sci 875 1999 326 339
77. E. Morsiani, P. Pazzi, A.C. Puviani, M. Brogli, L. Valieri, and P. Gorini Early experience with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients Int J Artif Organs 25 2002 192 202
78. J.C. Gerlach, K. Zeilinger, I.M. Sauer, T. Mieder, G. Naumann, and A. Grunwald Extracorporeal liver support: porcine or human cell based systems? Int J Artif Organs 25 2002 1013 1018
79. I.M. Sauer, K. Zeilinger, N. Obermayer, G. Pless, A. Grunwald, and A. Pascher Primary human liver cells as source for modular extracorporeal support-a preliminary report Int J Artif Organs 25 2002 1001 1005
80. M.P. van de Kerkhove, E. Di Florio, V. Scuderi, A. Mancini, A. Belli, and M. Dauri Phase I clinical trial with the AMC-bioartificial liver Int J Artif Organs 25 2002 950 959
81. Y.T. Ding, Y.D. Qiu, Z. Chen, Q.X. Xu, H.Y. Zhang, and Q. Tang The development of a new bioartificial liver and its application in 12 acute liver failure patients World J Gastroenterol 9 2003 829 832
82. J.F. Patzer II, G.V. Mazariegos, and R. Lopez Bioartificial liver program investigators. Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System J Am Coll Surg 195 2002 299 310
83. G.V. Mazariegos, J.F. Patzer II, R.C. Lopez, M. Giraldo, M.E. Devera, and T.A. Grogan First clinical use of a novel bioartificial liver support system (BLSS) Am J Transplant 2 2002 260 266
84. J. Rozga, M.D. Holzman, M.S. Ro, D.W. Griffin, D.F. Nuezil, and T. Giorgio Development of a hybrid bioartificial liver Ann Surg 217 1993 502 509
85. N. Arkadopoulos, O. Detry, J. Rozga, and A.A. Demetriou Livert assist systems; state of the art Int J Artif Organs 21 1998 781 787
86. D. Samuel, P. Ichai, C. Feray, F. Saliba, D. Azoulay, and J.L. Arulnaden Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation Transplantation 73 2002 257 264
87. A.J. Ellis, R.D. Hughes, J.A. Wendon, J. Dunne, P.G. Langley, and J.H. Kelly Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure Hepatology 24 1996 1446 1451
88. U. Heemann, U. Treichel, J. Loock, T. Philipp, G. Gerken, and M. Malagò Albumin dialysis in cirrhosis with superimposed acute liver injury. A prospective, controlled study Hepatology 36 2002 949 958
89. S.R. Mitzner, J. Stange, S. Klammt, T. Risler, C.M. Erley, and B.D. Bader Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled trial Liver Transpl 6 2000 277 286
90. K. Rifai, T. Ernst, U. Kretschmer, M.J. Bahr, A. Schneider, and C. Hafer Prometheus - a new extracorporeal system for the treatment of liver failure J Hepatol 39 2003 984 990
91. L.L. Kjaergard, J. Liu, B. Als-Nielsen, and C. Gluud Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review JAMA 289 2003 217 222
92. J.R. Gunsalus, D.A. Brady, S.M. Coulter, B.M. Gray, and A.S. Edge Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation Nat Med 3 1997 48 53
93. H. Nagata, M. Ito, J. Cai, A.S. Edge, J.L. Platt, and I.J. Fox Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation Gastroenterology 124 2003 422 431
94. M. Dandri, M.R. Burda, A. Gocht, E. Torok, J.M. Pollok, and C.E. Rogler Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation Hepatology 34 2001 824 833
95. D.F. Mercer, D.E. Schiller, J.F. Elliott, D.N. Douglas, C. Hao, and A. Rinfret Hepatitis C virus replication with chimeric human livers Nat Med 7 2001 890 891
96. R.Y. Calne, H.J. White, B.M. Herbertson, P.R. Millard, D.R. Davis, and J.R. Salaman Pig to babbon liver xenografts Lancet 1 1968 1176 1178
97. P. Ramirez, R. Chavez, M. Majado, V. Munitiz, A. Munoz, and Q. Hernandez Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days Transplantation 70 2000 989 998
98. A. Baquerizo, A. Mhoyan, M. Kearns-Jonker, W.S. Arnaout, C. Shackleton, and R.W. Busuttil Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation Transplantation 67 1999 5 18
99. Z.E. Holzknecht, S. Coombes, B.A. Blocher, T.B. Plummer, M. Bustos, and C.L. Lau Immune complex formation after xenotransplantation: evidence of type III as well as type II immnue reactions provide clues to pathophysiology Am J Pathol 158 2001 627 637
100. K. Paradis, G. Langford, Z. Long, W. Heneine, P. Sandstrom, and W.M. Switzer Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group Science 285 1999 1236 1241
101. W. Heneine, A. Tibell, W.M. Switzer, P. Sandstrom, G.V. Rosales, and A. Mathewes No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts Lancet 352 1998 695 699
102. Z. Pitkin, and C. Mullon Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system Artif Organs 23 1999 829 833
103. R. Kuddus, J.F. Patzer II, R. Lopez, G.V. Mazariegos, B. Meighen, and D.J. Kramer Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus Transplantation 15 2002 420 429